A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.

NCT05230186 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

PROCEDURE: Tumor Biopsy

Sponsor

TScan Therapeutics, Inc.